Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355856
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-04-04
Brief Title:
Efficacy Safety of DNN2217036 in Male Patients With Pattern Hair Loss
Sponsor:
Ache Laboratorios Farmaceuticos SA
Organization:
Ache Laboratorios Farmaceuticos SA
Study Overview
Official Title:
Phase IV National Unicentric Comparative Double-Blind Randomized Non- Inferiority Clinical Trial to Evaluate the Efficacy and Safety of DNN2217036 Compared to 10573048700 in the Treatment of Androgenetic Alopecia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPELLI
Brief Summary:
Evaluation of the efficacy and safety of DNN2217036 versus 10573048700 in the treatment of male pattern hair loss
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None